General Information of DTT (ID: TTY7ZHS)

DTT Name Toll-like receptor 2 (TLR2) DTT Info
Gene Name TLR2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
6 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cadi-05 DMPTCYB Prostate cancer 2C82.0 Phase 3 [1]
MCS-18 DMX4U0B Autoimmune diabetes 5A10 Phase 2 [2]
OPN-305 DM1IBRT Myelodysplastic syndrome 2A37 Phase 2 [3]
Lipoteichoic acid DMEMRW0 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [4]
MALP-2S DMBZ68C Pancreatic cancer 2C10 Phase 1/2 [5]
OM-174 DM2THBX Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Clinical Trial Drug(s)
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
F-50040 DMMG6W5 Melanoma 2C30 Discontinued in Phase 1 [7]
------------------------------------------------------------------------------------
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CBLB-612 DMCFR8U Radiation syndrome NF00 Investigative [8]
S-(Dimethylarsenic)Cysteine DMSCHL0 Discovery agent N.A. Investigative [9]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012 August 1; 1(5): 699-716.
2 The novel arthritis-drug substance MCS-18 attenuates the antibody production in vivo. Acta Microbiol Immunol Hung. 2008 Mar;55(1):15-31.
3 Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs. Circ Cardiovasc Interv. 2012 Apr;5(2):279-87.
4 Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccha... J Biol Chem. 2003 May 2;278(18):15587-94.
5 Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. Microbes Infect. 2011 Apr;13(4):350-8.
6 Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors. BMC Cancer. 2013 Apr 2;13:172.
7 Stability and CTL-activity of P40/ELA melanoma vaccine candidate. Biologicals. 2001 Sep-Dec;29(3-4):293-8.
8 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1752).
9 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.